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Abstract
Background: Foot-and-mouth disease virus (FMDV) uses a highly conserved Arg-Gly-Asp (RGD) triplet for
attachment to host cells and this motif is believed to be essential for virus viability. Previous sequence analyses of
the 1D-encoding region of an FMDV field isolate (Asia1/JS/CHA/05) and its two derivatives indicated that two
viruses, which contained an Arg-Asp-Asp (RDD) or an Arg-Ser-Asp (RSD) triplet instead of the RGD integrin
recognition motif, were generated serendipitously upon short-term evolution of field isolate in different biological
environments. To examine the influence of single amino acid substitutions in the receptor binding site of the RDD-
containing FMD viral genome on virus viability and the ability of non-RGD FMDVs to cause disease in susceptible
animals, we constructed an RDD-containing FMDV full-length cDNA clone and derived mutant molecules with RGD
or RSD receptor recognition motifs. Following transfection of BSR cells with the full-length genome plasmids, the
genetically engineered viruses were examined for their infectious potential in cell culture and susceptible animals.
Results: Amino acid sequence analysis of the 1D-coding region of different derivatives derived from the Asia1/JS/
CHA/05 field isolate revealed that the RDD mutants became dominant or achieved population equilibrium with
coexistence of the RGD and RSD subpopulations at an early phase of type Asia1 FMDV quasispecies evolution.
Furthermore, the RDD and RSD sequences remained genetically stable for at least 20 passages. Using reverse
genetics, the RDD-, RSD-, and RGD-containing FMD viruses were rescued from full-length cDNA clones, and single
amino acid substitution in RDD-containing FMD viral genome did not affect virus viability. The genetically
engineered viruses replicated stably in BHK-21 cells and had similar growth properties to the parental virus. The
RDD parental virus and two non-RGD recombinant viruses were virulent to pigs and bovines that developed
typical clinical disease and viremia.
Conclusions: FMDV quasispecies evolving in a different biological environment gained the capability of selecting
different receptor recognition site. The RDD-containing FMD viral genome can accommodate substitutions in the
receptor binding site without additional changes in the capsid. The viruses expressing non-RGD receptor binding
sites can replicate stably in vitro and produce typical FMD clinical disease in susceptible animals.
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Foot-and-mouth disease virus (FMDV) is an important
animal pathogen that causes a severe vesicular disease in
cattle, swine, sheep and other cloven-hoofed animals
[1,2]. The virus belongs to the Aphthovirus genus within
the Picornaviridae family [3]. The genome is a positive-
sense single-stranded RNA molecule that is encapsidated
by 60 copies of each of the four structural polypeptides
of which VP4 is internal and the others (VP1, VP2 and
VP3) are exposed [4]. It has been shown that VP1 is the
most variable among the capsid polypeptides, and it is
widely used to characterize field strains of FMDV to
provide data to support epidemiological investigations of
disease outbreaks among livestock.
A major, highly variable antigenic site of FMDV is
located at the exposed G-H loop comprising amino acids
134-160 of the capsid protein VP1 [4-6], which plays an
important role in cell infection and is also a major target
for protective host responses mediated via humoral
immunity [5,7-9]. This mobile loop contains a conserved
Arg-Gly-Asp (RGD) motif that has been shown to be a
major determinant in the interaction of the virus with
cell surface receptors of the integrin superfamily
[7,10,11]. Indeed, previous studies, using different
approaches, have indicated that naturally occurring field
isolates of FMDV bind to cells via these highly conserved
surface-exposed RGD residues [11,12]. In particular, it
has been reported that FMD viruses utilize multiple
RGD-dependent integrins of the avs u b g r o u pt oi n i t i a t e
infection, including avb3, avb6, avb1a n davb8 [13-17].
However, the RGD integrin recognition domain can
become dispensable upon in-vitro passage of FMDV:
multiple phenotypic changes that are associated with a
limited number of amino acid substitutions at the capsid
surface which may even include modifications within the
RGD triplet [18-21]. Tissue culture-adapted viruses can
use heparan sulfate (HS) as a receptor to enter cells
[18,22], and can also dispense with their RGD integrin-
binding motif [23]. These findings indicate the existence
of alternative RGD-independent pathways for FMDV
entry into cell.
In the present study we report that two viruses harbor-
ing alternative receptor binding sites (RDD or RSD) were
generated after short-term passage of an FMDV field iso-
late (Asia1/JS/CHA/05) in different environments. The
non-RGD receptor recognition motifs were stably main-
tained during subsequent passage in cell culture. To
study the ability of an RDD-containing FMD viral gen-
ome to accommodate substitution in receptor binding
site and non-RGD viruses to cause disease in susceptible
animals, we assembled an RDD-containing FMDV
(Asia1/JSp1c8) full-length cDNA clone and derived
mutant clones harboring RGD or RSD motif with a single
amino acid substitution (RDD®RGD, RDD®RSD) in the
receptor binding site. Following transfection of BSR/T7
cell with three full-length plasmids, the resulting viruses
were examined for their infectious potential in-vitro and
in-vivo.
Results
Sequence analysis of Asia1/JS/CHA/05 and its derivatives
Deduced amino acid sequence analysis of the 1D-encoding
region showed that Asia1/JS/CHA/05 had a consensus
RGD triplet at position 143-145 of VP1, while Asia1/
JSp1c8 obtained an alternative RDD triplet at this position.
However, careful inspection of the electropherograms
from the Asia1/JSM4 VP1 gene sequencing reactions
revealed the presence of two genetic subpopulations, one
with RGD and the other with RSD at receptor binding
site. To further investigate the genetic heterogeneity
within these samples, 10 biological clones containing VP1
genes of each Asia1/JS/CHA/05, Asia1/JSp1c8 and Asia1/
JSM4 were sequenced. The 10 clones obtained from each
of the Asia1/JS/CHA/05 and Asia1/JSp1c8 viruses respec-
tively encode RGD and RDD tripeptide at position
143-145 of VP1. For Asia1/JSM4, four clones encoded
RSD and six clones maintain the RGD motif at the same
position. These results were identical to the amino acid
sequence analysis performed by direct sequencing of PCR
amplicons. Additionally, amino acid sequence analysis of
the capsid-coding regions of Asia1/JS/CHA/05, Asia1/
JSp1c8, and Asia1/JSM4 showed that Asia1/JSp1c8 had
seven amino acid substitutions in the capsid region (1 in
1A, 3 in 1B, 1 in 1C and 3 in 1D; Table 1) compared with
Asia1/JS/CHA/05 and Asia1/JSM4.
Taken together, these results suggested that the RDD
mutants became dominant or obtained equilibrium with
the RGD and RSD subpopulations at an early phase of
Asia1/JS/CHA/05 quasispecies evolution. Since RDD and
RSD motifs are unusual in lacking the RGD integrin-
recognition sequence, additional multiple passages were
performed to determine its stability. Amino acid
sequence of the VP1 gene of the viruses obtained from
different passages of Asia1/JSp1c8 and Asia1/JSM4
revealed that the RDD and RSD sequence were geneti-
cally stable for at least 20 passages (Figure 1). The amino
acid sequences of the G-H loop of viruses derived from
different passages are summarized in table 2. Evidence
that FMDVs can contain an RDD or RSD receptor-bind-
ing site increases the quasispecies complexity around the
RGD-coding region.
Rescue of viable viruses from the full-length cDNA clones
To examine the influence of single amino acid substitu-
tions in the receptor binding site of the RDD-containing
FMD viral genome on virus viability and the ability of
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mals, we assembled a full-length cDNA clone of an
RDD-containing FMDV and derived mutant clones con-
taining RSD or RGD motifs with a single amino acid
substitution in the receptor binding site (RDD®RGD,
RDD®RSD). BSR-T7/5 cells were independently trans-
fected with linearized-plasmids, pRDD, pRGD and
pRSD. The typical FMDV cytopathic effect was clearly
visible at 36 h post-transfection with pRDD and pRGD,
and at 48 h post-transfection with pRSD. The three res-
cued viruses were named FMDV-RDD, FMDV-RGD,
and FMDV-RSD, respectively.
To increase the virus titers, all rescued viruses were sub-
jected to serial passage in BHK-21 cells, after which the
VP1 sequence was analyzed to confirm that the recovered
viruses had maintained the cDNA-encoded receptor
binding motifs (Table 2). When the growth characteristics
of the rescued viruses were compared with the parental
virus Asia1/JSp1c8 by one-step growth kinetics assays, res-
cued viruses showed similar growth properties to the par-
ental virus (Figure 2a). In addition, the plaque sizes of the
parental virus and the rescued viruses were also similar
(Figure 2b). These results suggest that single amino acid
substitutions in the receptor binding site of Asia1/JSp1c8
virus do not affect virus viability.
The pathogenicity of the rescued viruses in cattle and
swine
To investigate the pathogenicity of the non-RGD viruses
in the natural host, we performed direct inoculation of
parental virus Asia1/JSp1c8 and recombinant viruses
(FMDV-RSD and FMDV-RDD) in cattle and pigs. After
Table 1 Comparison of the P1 amino acid sequence of Asia1/JS/CHA/05, Asia1/JS/p1c8, and Asia1/JSM4
Capsid region Amino acid residue position
a Asia1/JS/CHA/05 Asia1/JSM4 Asia1/JS/p1c8
1A 73 S S N
1B 107 I I V
132 E E K
134 D D G
1C 133 T T A
1D 144 G G/S D
154 N N S
202 K K E
a Amino acid residues are numbered from the amino terminus to the carboxyl terminus. Single letter amino acid code is used.
Figure 1 Sequencing electropherograms of the VP1 PCR-amplicons of derivatives derived from Asia1/JSM4 and Asia1/JSp1c8.T h e
nucleotides encoding receptor-binding tripeptide are boxed, (a, b, c) represent sequencing electropherograms of Asia1/JSM6c5, Asia1/JSM6c15,
and Asia1/JSM6c20, respectively; (c, d, e) represent sequencing electropherograms of Asia1/JSp1c8, Asia1/JSp1c15, and Asia1/JSp1c20, respectively.
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lyzed, including fever, clinical score, and viremia. The
animals, except for the FMDV-RSD-inoculated animals,
showed fever and extensive tissue damage at the inocula-
tion sites by day 1 and achieved the maximal score of
lesions on day 2-4. Some FMDV-RSD-inoculated animals
developed fever and tissue damage by day 2 and achieved
the maximal score of lesions on day 3-5. Two animals
(infected with FMDV-RSD) had no evidence of tissue
damage, except for occasional depression and anorexia
when their body temperatures rose. The Asia1/JSp1c8
and FMDV-RDD viruses produced more extensive tissue
damage at the injected sites and induced fever and vesi-
cles a day earlier than in the FMDV-RSD-inoculated ani-
mals. There were significant differences in lesion scores
between RDD viruses (Asia1/JSp1c8 and FMDV-RDD)
and RSD virus (P < 0.05, P < 0.05), however, no signifi-
cant differences in lesion scores between cattle and pigs
(P > 0.05). The lesion scores for the inoculated animals
are summarized in table 3 and figure 3 shows the rectal
temperature of all of the inoculated animals. The disease
was characterized by viremia in all inoculated animals,
including the animals that did not generate vesicular
lesions. The level of viremia increased following inocula-
tion, typically reaching a peak level after two or three
days then decreasing to zero by day 8. In contrast to the
lesion scores, there were no significant differences caused
by viruses or species in terms of the maximum viremia
(P = 0.56), time of maximum viremia (P = 0.75) or time
of maximum rate of increase in viremia (P = 0.69). Virus
RNA copies in the blood of the inoculated animals are
summarized in table 4.
Vesicular fluid was collected from inoculated animals,
and each sample was separately processed for RT-PCR
and nucleotide sequencing. The results revealed that the
original receptor-binding motif did not change during
growth in vivo.
Discussion
The RGD integrin-binding motif within VP1 is highly
conserved among FMDV field isolates, and is generally
considered essential for virus viability via its interaction
with cellular integrin heterodimers [24-26]. Biochemical
evidence that small peptides containing the RGD
sequence inhibited the adsorption of the virus to tissue
culture cells [11], and genetically engineered virions con-
taining either mutations or deletions of the RGD
sequence were unable to bind to cells or cause disease in
susceptible animals [12,25,27]. However, the RGD triplet
may be dispensable upon short-term evolution of the
virus harboring it in a constant environment [21,28,29].
In the present report, we have documented that non-
RGD derivatives arose serendipitously during short-term
passage of a FMDV field isolate in vitro and in vivo. One
Table 2 Comparison of amino acid sequence at G-H loop of VP1 of the viruses derived from different origins and full-
length plasmids
Virus/plasmid Encoded G-H loop amino acid sequence
c Additional amino acid changes in VP1
Asia1/JS/CHA/05 TTYGEESSRRGDLAALARRVNNRLPTS -
Asia1/JSp1 TTYGEESSRRGDLAALARRVNNRLPTS -
Asia1/JSp1c4 TTYGEESSRRDDLAALARRVSNRLPTS N154S
Asia1/JSp1c8 TTYGEESSRRDDLAALARRVSNRLPTS N154S
Asia1/JSp1c20 TTYGEESSRRDDLAALARRVSNRLPTS N154S
Asia1/JSM4 TTYGEESSRRGDLAALARRVNNRLPTS -
TTYGEESSRRSDLAALARRVNNRLPTS -
Asia1/JSM6c20 TTYGEESSRRGDLAALARRVNNRLPTS -
TTYGEESSRRSDLAALARRVNNRLPTS -
pRDD TTYGEESSRRDDLAALARRVSNRLPTS -
pRSD TTYGEESSRRSDLAALARRVSNRLPTS -
pRGD TTYGEESSRRGDLAALARRVSNRLPTS -
FMDV-RDD
a TTYGEESSRRDDFAALARRVSNRLPTS L146F
FMDV-RSD
a TTYGEESSRRSDLAALARRVSNRLPTS N154S
FMDV-RGD
a TTYGEESSRRGDFAALARRVSNRLPTS L146F
FMDV-RDD/pig
b TTYGEESSRRDDLAALARRVSNRLPTS -
FMFV-RDD/bovine
b TTYGEESSRRDDLAALARRVSNRLPTS -
FMDV-RSD/pig
b TTYGEESSRRSDLAALARRVSNRLPTS -
FMDV-RSD/bovine
b TTYGEESSRRSDLAALARRVSNRLPTS -
a The rescued viruses were passaged 20 times in cell culture.
b Virus recovered from vesicular lesions, away from the inoculation site.
c Sequence data were obtained by RT-PCR of the VP1 capsid region. The dashes represent receptor binding triplet of the viruses derived from different origins
and full-length plasmids.
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binding site was obtained from the serotype Asia 1 field
isolate after a single cattle-to-pig transmission and subse-
quent BHK-21 in vitro passage. Sequence analysis of 10
biological clones of the VP1 encoding region of this
population demonstrated that RDD viruses instead of the
original RGD virus became predominant at an early
phase of Asia1/JS/CHA/05 quasispecies evolution. Unex-
pectedly, however, both RGD and RSD viruses were
obtained from the Asia1/JSM4 population that were gen-
erated after four serial passages of the Asia1/JS/CHA/05
field isolate in suckling mice, via intraperitoneal inocula-
tion. The population equilibrium of RSD mutant and
ancestor viruses was maintained after 20 passages of the
Asia1/JSM6 population in BHK-21 cells. Although RDD-
or RSD-containing FMDV are unusual, they were geneti-
cally stable upon extended replication in cell culture. Our
results suggest that, in the context of the capsid proteins
of Asia1/JS/CHA/05, a highly conserved RGD motif is
not essential for replication in vitro and in vivo, suggest-
ing functional flexibility of FMDV to enter cells in
response to environmental modifications.
Like other RNA viruses, FMDV exists as closely
related but non-identical genomes, termed viral quasis-
pecies [30,31]. Genetic diversity is an intrinsic property
of the quasispecies, which arise due to the lack of proof-
reading activity during viral genome replication, a short
replication cycle, and other environmental selective
pressures [32,33]. Our observations showed that evolu-
tion of FMDV population exhibited receptor binding
motif diversity (genetic diversity) subjected to short-
term passage of field isolate in different environments.
From the standpoint of RNA virus population evolution,
one possible scenario could explain this observation.
The early interactions between viruses and host cells
exert major selective force on virus populations, thus,
the variants (RSD- and RDD-containing viruses) may
already be present at low frequency in the natural popu-
lation that are possibly more fit in new environments
and become dominant strains. While this presumption
is contrary to the view that the RGD triplet is highly
conserved among natural isolates of FMDV, there is
direct evidence that an RDD containing field virus was
isolated from pigs during a type Asia 1 FMD outbreak
in China. RDD-containing FMDV VP1 genes were
a m p l i f i e df r o ms h e e po e s o phageal-pharyngeal fluids
(OP-fluids) collected during 2006 from a sheep herd in
the region of China that had endemic Asia 1 serotype
FMDV [34,35]. The emergence of these non-RGD
mutants in nature is likely to be influenced by specific
epidemiological and immunological aspects of host-virus
interaction as well as the quasispecies composition of
the viral population [36-39].
The molecular basis for this apparent relaxation of the
requirement for the precise RGD sequence is not well
understood, but functional replacements within the
RGD triplet allow the use of an alternative receptor for
entry of FMDV in BHK-21 cells. Since other FMDV
lack the RGD motif, host cell recognition may be
mediated through another integrin receptor or a non-
integrin pathway, or use a third receptor (neither integ-
rin-based nor HS) for entry into the host cell [18,21,40].
Further studies are required to analyze the interaction
of these mutants with the major FMDV integrin recep-
tors avb3, avb6, avb1a n davb8 identified to date, and
to understand whether these viruses obtain alteration of
cell tropism, antigenicity, and virulence.
To examine the influence of single amino acid substitu-
tions in the receptor binding site of RDD-containing
FMD viral genome on virus viability and the ability of
non-RGD viruses to cause disease in susceptible animals,
Figure 2 Growth characteristics of three rescued viruses in cell
culture compared with parental virus. (a), One-step growth
curves of the parental and three cloned viruses. (b), Morphology of
plaques formed in BHK-21 cell monolayers by the parental and
three cloned viruses.
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and derived mutant molecules with RGD or RSD recep-
tor recognition motifs. Following transfection of BSR
cells with these clones, three recombinant viruses were
rescued, in particular, six other amino acid differences in
the P1 capsid region of Asia1/JS/CHA/05 and Asia1/
JSM4 (compared with Asia1/JS/p1c8) did not affect res-
cue of viable RGD- and RSD-harboring viruses. Further-
more, in vitro growth properties of these viruses did not
differ significantly. Our results showed that Asia1/JS/
p1c8 viral genome can tolerate substitutions in the recep-
tor binding site with no other changes in the capsid. The
ability of the Asia1/JS/p1c8 viral genome to tolerate sub-
stitution of receptor binding sites may depend on the
capsid sequence, because the Asp-143 Gly change of
receptor recognition site was lethal in the context of the
capsid proteins of FMDV C-S8c1. However, the same
replacement yielded viable viruses in the context of the
capsid protein of FMDV C-S8c1p100 and C-S8c1p213
[21,41].
To assess the ability of non-RGD FMD viruses to cause
disease in naturally susceptible animals, we performed
experiment infections of cattle and pigs using the Asia1/
JS/p1c8 and two non-RGD recombinant viruses. Subse-
quent experiments showed that all viruses were able to
cause disease in cattle and pigs and produce rapid onset
of clinical signs, characteristic of infection with RGD
field strains. The disease was characterized by viremia in
all inoculated animals, including the individuals that did
not generate vesicular lesions. Amongst these viruses, the
RSD virus produced less tissue damage at the inoculation
sites and induced fever and vesicles a day later than in
the animals inoculated with RDD-containing viruses,
which indicated a different degree of disease severity.
The different virulence of these viruses was also sup-
ported by the maintenance of original receptor recogni-
tion sequence in vesicle samples obtained from infected
animals. The reason for low virulence of RSD virus,
which may bear on receptor usage, needs to be further
explored. These observations are particularly interesting,
since the presence of an RGD motif is believed to be the
main determinant to direct FMDV to integrin-containing
target tissues during infection in the natural host [42]. In
addition, information currently available indicates that
FMDV utilizes integrins for entry in the natural host, and
there is no evidence of the use of alternative receptors in
vivo [5,14,28]. Therefore, our results further support the
possibility that a non-RGD-integrin interaction could be
responsible for the generation of FMD in the natural
host. Our study was the first to demonstrate the ability of
an RDD containing natural isolate to cause disease in
naturally susceptible animals, and will provide knowledge
about the in vivo pathogenesis of non-RGD viruses.
Conclusion
FMDV quasispecies evolving in a different biological
environment gained the capability of selecting different
receptor recognition sites. Thus, the early interaction
between the viruses and the host cells may exert major
selective pressure on FMDV populations that contributes
to the evolution and functional flexibility of FMDV to
enter cells. Our studies using two non-RGD FMDVs not
only show that there was an increase in the number of
viable mutants with substitutions in the receptor-binding
region, but also provide useful tools for studies of cell
recognition by FMDV. Based on an RDD-containing
Table 3 Lesion scores of all animals on days-post inoculated
Virus Animal no. Lesion scores of days-post inoculation
a
Day1 Day2 Day3 Day4 Day5 Day6 Day7 Day8
Asia1/JSp1c8 Bovine88 1 3 5 55555
Bovine91 1 3 3 44444
Pig451 1 4 5 55555
Pig453 1 1 2 44444
Pig454 1 3 5 55555
FMDV-RDD Bovine 96 1 3 4 55555
Bovine 99 1 3 5 55555
P i g 4 5 8 11333333
P i g 4 5 9 12455555
P i g 4 6 0 14555555
FMDV-RSD Bovine 100 0 0 0 00000
Bovine 101 0 0 3 33333
P i g 4 6 1 01334444
P i g 4 6 2 00000000
P i g 4 6 5 02333333
a Lesion scores were calculated as described by Rieder et al. (2005).
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containing recombinant viruses were rescued, and single
amino acid substitutions in the receptor-binding site did
not affect virus viability. The viruses expressing non-
RGD receptor binding sites can replicate stably in vitro
and induce the disease in susceptible animals.
Methods
Viruses and cells
FMDV Asia1/JS/CHA/05 utilized in this study was ori-
ginally isolated from cattle in Wuxi, Jiangsu Province,
China, in 2005. The complete genome sequence of this
virus was published in GenBank (GenBank Accession:
Figure 3 Rectal temperatures of all FMDV inoculated animals. (a), Temperatures in Asia1/JSp1c8-inoculated animals; (b), Temperatures in
FMDV-RDD-inoculated animals; (c), Temperatures in FMDV-RSD-inoculated animals.
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Page 7 of 12EF149009). FMDV Asia1/JSp1c8 is a viral population
resulting from eight serial passages of Asia1/JSp1 virus
in BHK-21 cells, as previously described [43], which was
obtained from a pig infected by placing it in contact
with an Asia1/JS/CHA/05 virus-inoculated cattle. FMDV
Asia1/JSM4 is a viral population resulting from four
serial passages of Asia1/JS/CHA/05 virus in suckling
mice, via intraperitoneal inoculation. Figure 4 shows the
passage history of Asia1/JS/CHA/05 field isolate in dif-
ferent environments.
BSR-T7/5 cells (a cell line derived from BHK-21,
which constitutively expresses T7 RNA polymerase
[44]) were maintained in Glasgow minimal essential
medium (GMEM) supplemented with 4% tryptose
phosphate broth, 10% fetal bovine serum (FBS) and
were additionally provided with G418 (1 mg mL
-1)o n
every second passage to ensure maintenance of the T7
polymerase gene. BHK-21 cells were grown in Eagle’s
minimal essential medium (EMEM) supplemented with
10% FBS.
Table 4 Virus RNA copies detected in the blood of all animals on days-post inoculated
Virus Animal no. Virus RNA copies in the blood of days-post inoculation(× 10
6)
b
Day1 Day2 Day3 Day4 Day5 Day6 Day7 Day8
Asia1/JSp1c8 Bovine88 0.1 14 4 0.9 2.6 1.1 0 0
Bovine91 0.3 1.0 14.5 6 0.1 0 0 0
Pig451 0.04 17 4.6 2.1 0.4 0 0 0
Pig453 0.06 4 11.7 1 0.3 0 0 0
Pig454 0.2 9 96.4 10 5 1.8 0.2 0
FMDV-RDD Bovine 96 2 17.4 42.9 8.8 3.1 4.2 0 0
Bovine 99 9 78.8 9.4 2.3 0.3 0 0 0
Pig 458 0.03 0.6 22.5 5.5 3.9 1 0.2 0
Pig 459 0.2 2.3 30.2 14.4 3.1 0.2 0 0
Pig 460 0.3 2.8 36.9 15.1 2 0.3 0 0
FMDV-RSD Bovine 100 0.02 0.2 7.8 3.8 2.1 0.2 0 0
Bovine 101 0.1 3 12.6 16.2 9.8 6.2 2.3 0
Pig 461 0.4 6.9 19.6 10.5 5.1 2.8 0.5 0
Pig 462 0 0.1 14.6 7.1 1 0.9 0 0
Pig 465 0.02 3.6 16.6 10.4 5.2 1.1 0.9 0
b The amount of virus in the blood was measured by real-time quantitative RT-PCR assay as described in materials and methods. Blood samples were collected at
1-8 dpi in inoculated animals.
Figure 4 Passage history and origin of FMDVs used in this study derived from a field isolate, Asia1/JS/CHA/05. The Asia1/JSp1c8 and
Asia1/JSM4 population with alternative RGD motifs were occasionally found by two different passage strategies (A and B). Nomenclature used
for the passaged viruses is as follows: “p” denotes passage number in pig; “M” denotes passage number in suckling mice and “c” denotes
passage number in BHK-21 cells. The virus used for construction of full-length infectious cDNA clone is underlined.
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RNA was extracted from virus stock of Asia1/JSp1c8,
Asia1/JSM4, and Asia1/JS/China/2005 using RNeasy mini
kit (Qiagen, Valencia, CA) according to the manufacturer’s
instructions. Viral cDNAs were synthesized from the viral
RNAs, as previously described [45]. Briefly, viral cDNAs
were synthesized using M-MLV reverse transcriptase
(Invitrogen, Carlsbad, CA, USA) with NK61 primer (5’-
GACATGTCCTCCTGCATCTG-3’) and the VP1 coding
regions were amplified by PCRs with the primer pair
NK61/VP31 (5’-TAGTGCTGGYAARGACTTTG-3’). The
PCRs were performed using PrimeSTAR HS DNA Poly-
merase (Takara, Dalian, China). PCR amplifications were
carried out for 30 cycles of denaturation at 98°C for 20 s,
annealing at 68°C for 1 min, and extension at 72°C for 8
min. Following amplification, the cDNA fragments were
purified from agarose gels using a kit (Qiagen) and
sequenced by Sunny Biotech (Shanghai, China). In order
to detect heterogeneity of the VP1 gene, the amplicons
were cloned into a pGEM-T vector (Promega, Madison,
WI, USA) using standard molecular cloning techniques
[46] and plasmids derived from 10 positive clones for each
sample were sequenced. Additionally, the capsid-encoding
regions of Asia1/JSp1c8, Asia1/JSM4, and Asia1/JS/CHA/
05 were also amplified and sequenced.
Construction of genome-length cDNA clone of Asia1/
JSp1c8 and derivation of G-H loop VP1 mutants
Recombinant DNA techniques were used according to
standard procedures [46]. The viral RNA of Asia1/JSp1c8
was used as a template for first-strand cDNA synthesis
with M-MLV reverse transcriptase by using specific oli-
gonucleotide primers (E1’,E 2 ’,E 3 ’,E 4 ’,a n dE 5 ’). A total
of five fragments (E1-E5; Figure 5), covering the complete
virus genome, were subsequently amplified by PCR. Two
fragments (E1 and E2 corresponding to nucleotide 1-390,
362-700) were amplified with the E1/E1’ and E2/E2’ pri-
mer pairs by PCR. T7 RNA polymerase promoter was
introduced in the E1 primer. Cycling conditions for both
PCRs were as follows: initial denaturation at 94°C for 1
min, 30 cycles of 98°C for 20 s, 68°C for 40 s, and then
72°C for 8 min. E12 fragments were generated by overlap
PCR fusion E1 and E2 fragments with primer pair E1/E2’.
PCR amplifications involved initial denaturation at 94°C
for 1 min, followed by 30 cycles of 98°C for 20 s, 68°C for
1 min, then 72°C for 8 min. The amplicons were ligated
into the pGEM-T vector, leading to the positive clone
pGEME12. The other three fragments (E3, E4 and E5
corresponding to nucleotide 690-3101, 3090-5437 and
5425 to the 3’-end) were produced by PCR with primer
pairs E3/E3’, E4/E4’, E5/E5’. Cycling parameters for three
PCRs were as follows: initial denaturation at 94°C for 1
min, 30 cycles of 98°C for 20 s, 68°C for 3 min, and then
7 2 ° Cf o r1 0m i n .T h eE 3 ,E 4a n dE 5a m p l i c o n sw e r e
cloned into the M-pSK vector with XbaI/PstI, PstI/EcoRI,
and EcoRI/NotI sites, the resulting positive plasmids were
designated pSKE3, pSKE4, and pSKE5, respectively. The
M-pSK vector derived from pBluescriptSK (+) by
removed T7 promoter and modified some restriction
enzyme sites in the vector sequence, was synthesized by
GenScript Biotech Company (Nanjing, China). To intro-
duce the genetic tags into theg e n o m eo fA s i a 1 / J S p 1 c 8 ,
recombinant plasmid pSKE3Δ, which contained two
synonymous mutations (1185A®G, 1185T®C) to elimi-
nate the EcoRIs i t ei nt h eE 3f r a g m e n t ,w e r ec o n s t r u c t e d
by oligonucleotide-directed mutagenesis with PCR ampli-
fication of the parent plasmid pSKE3 using p1/p1’primer
pair. PCR amplification was carried out for 18 cycles of
denaturation at 95°C for 30 s, annealing at 55°C for 1
min, and extension at 68°C for 8 min. All recombinant
plasmids were confirmed by complete DNA sequencing.
Primers used to construct full-length cDNA clones of
Asia1/JSp1c8 are listed in table 5.
The full-length virus genome was assembled by a ser-
ies of ligation steps (Figure 5). First, a 2400-bp XbaI-
PstI fragment was release from plasmid pSKE3Δ and
cloned into plasmid pGEME12 digested with PstI and
XbaI, leading to the construct pGEME123. A 3123-bp
SpeI-PstI fragment of the pGEME123 was inserted into
the pSKE4 plasmid digested with SpeI and PstI,t h e
resulting plasmid pSKE1234. A 5429-bp SpeI-EcoRI frag-
ment was release from plasmid pSKE1234 and ligated
Figure 5 Strategy used to construct FMDV Asia1/JSp1c8 full-length cDNA clone, pRDD. The location of restriction enzyme cleavage sites
used to assemble the subcloned RT-PCR fragments (E1, E2, E3, E4, E5 and E12) are shown (numbered relative to nucleotide position in the virus
genome). Thick lines and an open box represent the untranslated regions and the open-reading frame for the viral polyprotein, respectively. The
thin line represents the vector sequence. FMDV cDNA is under the control of the T7 promoter.
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Page 9 of 12into plasmid pSKE5 digested with EcoRI and SpeI,t h e
resulting plasmid named pRDD, which contained gen-
ome-length cDNA clone of Asia1/JSp1c8, was sequenced
to confirm sequence fidelity.
Overlapping PCRs were used to introduce amino acid
substitutions (144 D (gat) to G (ggt), 144 D (gat) to S
(agt)) into the structural protein VP1 of Asia1/JSp1c8
virus. Individual parts were amplified with primer pairs
TR1/TR1’, TR2/TR2’, TR1/TR3’ and TR3/TR2’ (Table 5),
and then both overlapping PCR fusion reactions were
performed by mixing PCR-amplified fragments with
TR1/TR2’ primer pair. The parameters of two PCRs as
following: initial denaturation at 94°C for 1 min, 30 cycles
of 98°C for 20 s, 68°C for 1 min, and then 72°C for 8 min.
The two fused PCR fragments were digested with EcoRI
and SacII and cloned into the full-length plasmid pRDD.
The mutated full-length cDNA clones named pRGD, and
pRSD, respectively, were sequenced through the entire
amplified regions to confirm the presence of the expected
modifications.
Virus rescue
The plasmids pRDD, pRGD and pRSD were linearized
with NotI and purified from agarose gels with columns
(Qiagen). BSR-T7/5 cells (4-6 × 10
5 in a six-well plate)
were transfected with mixtures containing 2 μg each of
three linearized plasmids and 10 μL Lipofectamine 2000
(Invitrogen) according to the manufacturer’s directions. As
a negative control, Lipofectamine 2000 was also used to
transfect BSR-T7/5 cells. After 6 h of incubation at 37°C,
the cells were added to GMEM supplemented with 10%
FBS and further incubated for 72 h at 37°C with 5% CO2.
The cell culture supernatants were harvested at 72 h post-
transfection and were then serially passaged 10 times on
BHK-21 cells to increase virus titers.
Replication kinetics of rescued FMDVs
Growth kinetics of the viruses was determined in BHK-21
cells. Confluent monolayers in 60 mm diameter plates
were infected at a multiplicity of infection (MOI) of 10
PFU per cell with Asia1/JSp1c8 virus and the three geneti-
cally engineered viruses. After adsorption for 1 h, the
monolayers were washed with 0.01 M phosphate-buffered
saline (PBS; pH7.4), and maintained in DMEM supple-
mented with 2% FBS at 37°C with 5% CO2.T h ev i r u s -
infected supernatants were collected at 4, 8, 12, 16 and
24 h after inoculation. Plaque assays were performed using
gum tragacanth overlay and crystal violet staining, as pre-
viously described [47]. Virus titers (plaque-forming units
(pfu) mL
-1)w e r ed e t e r m i n e do nB H K - 2 1 ,a sd e s c r i b e d
elsewhere [48].
Animal experiments
Nine 2-month-old pigs and six 1-year-old bovines were
divided into three groups, each consisting of three pigs
and two bovines. All animals were seronegative for
FMDV non-structural protein (NSP) antibodies prior to
experimental infection. Two non-RGD recombinant
Table 5 Sequences of the primers used for the construction of a full-length cDNA clone and mutants of FMDV Asia1/
JSp1c8
Name Nucleotide Sequence (5’®3’) Nucleotide Position (nt)
E1 CAGGATCCTAATACGACTCACTATAGGGTTGAAAAGG GGCGCTAGGGTC 1-21
E1’ TAAAACTTAGGGGGGGGGGGGGGGGGGGGTGAAAG 361-390
E2 TTTCACCCCCCCCCCCCCCCCCCCCTAAGTTTTAC 362-391
E2’ CCTCTAGA CCTGGAAAGACCAGGC 677-700
E3 AGGTCTAGAGGGGTGACATTTTGT 690-713
E3’ GTCTGCAGCAGAAAGGTAAGGGAT 3078-3101
E4 CTGCTGCAGACTATGCTTACACTG 3090-3113
E4’ AAAGAATTC AATTGCTGCCTCATG 5414-5437
E5 AATTGAATTCTTTGAGGGAATGGTGCAC 5425-5452
E5’ TTGCGGCCGCTTT(38) 3’end
P1 ACAAGGAAAGATGGAGCTCACACTTCACAAC 1168-1198
P1’ GTTGTGAAGTGTGAGCTCCATCTTTCCTTGT 1168-1198
TR1 ACTGCATTCATTCTGAGTGGGA 2960-2984
TR1’ GGCAAGATCACCACGCCGCGAGGA 3679-3703(D®G)
TR2 TCCTCGCGGCGTGGTGATCTTGCC 3679-3703(D®G)
TR2’ 5’-GAAGAAACTCGAGGCGACTTTGAC-3’ 4342-4366
TR3 TCCTCGCGGCGTAGTGATCTTGCC 3679-3703(D®S)
TR3’ GGCAAGATCACTACGCCGCGAGGA 3679-3703(D®S)
Nucleotide positions of primers used for cloning are shown: numbering according to Asia1/JS/CHA/05 (Genbank Accession: EF149009). T7 promoter sequences
are marked with italic type, the restriction sites are highlighted by underlining, silent mutations within the viral sequence are underlined and amino acid changes
are shown in brackets.
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Page 10 of 12viruses and Asia1/JSp1c8 virus with a titer of 1.6 × 10
7
pfu mL
-1,1 . 3×1 0
7 pfu mL
-1, and 1.0 × 10
7 pfu mL
-1,
respectively, were used to separately inoculate animals.
Each pig was inoculated with 2 mL inoculum via the
intramuscular route, each bovine received 1 mL intra-
muscularly and 1 mL via the tongue. Following inocula-
tion, animals were carefully scored for appearance of
lesions at inoculation sites and at other sites. Lesion
scores were based on the number of sites affected that
were distinct from actual injection sites. Scores were cal-
culated as described by Rieder et al [28].
The viral load in the blood was assessed by real-time
quantitative RT-PCR using the RNA Master SYBR green I
kit (Roche), as specified by the manufacturer. Quantifica-
tion was relative to a standard curve obtained with known
amounts of FMDV O/CHA/99 RNA, using a procedure
that has been described previously [49], except that the
primers (patent pending) targeted the 3D non-structural
protein were altered. The viral RNA was extracted from
vesicular fluid (collected on selected days), reverse tran-
scribed, and sequenced through the entire VP1 region as
described above.
All animal studies were approved by the Review Board of
Lanzhou Veterinary Research Institute, Chinese Academy
of Agricultural Sciences (Permission number: SYXK-GAN-
2004-0005). All animals used in this study were humanely
bred during the experiment and euthanasia was carried out
at the end of the experiment to reduce suffering.
Statistical analysis
Changes in viral titer over time for the in vitro passage
experiments were modeled using linear models with
virus and time since infection (treated as a factor) as
fixed effects. Model selection proceeded by stepwise
deletion of non-significant terms (as judged by F-tests)
starting from a model including virus, time since infec-
tion and an interaction between these factors.
Lesion scores over time were modeled using linear
mixed models with virus and species as fixed effects and
animal identification number as a random effect. Model
selection proceeded by stepwise deletion of non-signifi-
cant terms (as judged by the Akaike information criter-
ion; AIC) starting from a model including virus, species
and an interaction between these factors.
The change in viremia (y, measured as viral RNA copy
number) over time (t) was described using the following
function,
y(t)=α

t
β
β2/γ 2
exp

−
β
γ 2(tj − β)

,
where a is the maximum viremia, is the time at which
maximum viremia occurs and is the time before (after)
maximum viremia at which the maximum rate of
increase (decrease) in viremia occurs. Parameters for
each animal were estimated by fitting the curve to the
data using the method of least-squares. Estimates for
each animal were compared using Kruskal-Wallis tests
to identify significant differences (P < 0.05) amongst ani-
mals infected with differentv i r u s e s .T h i sa n a l y s i sw a s
done for all animals and then repeated for cattle only
and for swine only. Animal B99 was excluded from the
analysis of viremia because robust estimates could not
be obtained for the parameters.
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